Company Filing History:
1 out of 1,650 
1 out of 3 Years Active: 2018
Title: Mary Beth Scholand: Innovating COPD Assessment Techniques
Introduction
Mary Beth Scholand, an innovative inventor based in Salt Lake City, UT, has made significant contributions to the field of respiratory health. With a focus on chronic obstructive pulmonary disease (COPD), she has developed methods and apparatus that enhance the assessment and understanding of disease progression.
Latest Patents
Scholand holds a patent titled "Apparatus, compositions, and methods for assessment of chronic obstructive pulmonary disease progression among rapid and slow decline conditions." This patent describes methods for generating and isolating a comprehensive repository of respiratory biomarkers. These biomarkers help determine whether an individual has normal or abnormal pulmonary function. Specifically, her work provides tools for diagnosing COPD and identifying whether patients experience rapid or slow lung decline. The innovative content repository aids in diagnosis, therapeutic discovery, condition management, health maintenance, and links COPD with lifestyle, environmental factors, and genetic susceptibility.
Career Highlights
Throughout her career, Mary Beth Scholand has worked with notable organizations such as the University of Utah Research Foundation and Lineagen, Inc. Her involvement in these institutions highlights her commitment to advancing respiratory health research and innovation.
Collaborations
Scholand has collaborated with esteemed colleagues, including John Hoidal and Mark F. Leppert. These professional relationships underscore the importance of teamwork in her research efforts and contribute to the successful development of COPD assessment methods.
Conclusion
Mary Beth Scholand has established herself as a prominent figure in the field of pulmonary health through her innovative approaches to assessing chronic obstructive pulmonary disease. Her work not only furthers scientific knowledge but also provides valuable tools for diagnosing and managing COPD, ultimately improving the quality of care for affected individuals.